During the past decade, VA Puget Sound Health Care System Seattle Division, Seattle, WA conducted 124 clinical trials. In the 10-year time frame, 124 clinical trials started and 101 clinical trials were completed, i.e. on average, 81.5% percent of trials that started reached the finish line to date. In the past 5 years, 60 clinical trials started and 36 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "VA Puget Sound Health Care System Seattle Division, Seattle, WA" #1 sponsor was "VA Office of Research and Development" with 102 trials, followed by "US Department of Veterans Affairs" with 55 trials sponsored, "Seattle Institute for Biomedical and Clinical Research" with 34 trials sponsored, "University of Washington" with 25 trials sponsored and "Fred Hutchinson Cancer Center" with 25 trials sponsored. Other sponsors include 62 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "VA Puget Sound Health Care System Seattle Division, Seattle, WA" #1 collaborator was "VA Puget Sound Health Care System" with 27 trials as a collaborator, "National Cancer Institute (NCI)" with 19 trials as a collaborator, "University of Washington" with 17 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 7 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 6 trials as a collaborator. Other collaborators include 174 different institutions and companies that were collaborators in the rest 134 trials.

According to Clinical.Site data, the most researched conditions in "VA Puget Sound Health Care System Seattle Division, Seattle, WA" are "Posttraumatic Stress Disorder" (13 trials), "Depression" (9 trials), "Prostate Cancer" (9 trials), "Alzheimer's Disease" (8 trials) and "Refractory Chronic Lymphocytic Leukemia" (8 trials). Many other conditions were trialed in "VA Puget Sound Health Care System Seattle Division, Seattle, WA" in a lesser frequency.

Most popular intervention types in "VA Puget Sound Health Care System Seattle Division, Seattle, WA" are "Drug" (132 trials), "Behavioral" (78 trials), "Other" (51 trials), "Procedure" (42 trials) and "Device" (25 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (27 trials), "Cyclosporine" (11 trials), "Mycophenolate Mofetil" (11 trials), "Total-Body Irradiation" (10 trials) and "Prazosin" (9 trials). Other intervention names were less common.

The vast majority of trials in "VA Puget Sound Health Care System Seattle Division, Seattle, WA" are 265 trials for "All" genders, 34 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are 83 active trials in "VA Puget Sound Health Care System Seattle Division, Seattle, WA". 9 are not yet recruiting, 45 are recruiting, 24 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 187 completed trials in VA Puget Sound Health Care System Seattle Division, Seattle, WA, undefined suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in VA Puget Sound Health Care System Seattle Division, Seattle, WA, 11 "Phase 1" clinical trials were conducted, 62 "Phase 2" clinical trials and 61 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 23 trials, and there were also 116 trials that are defined as “Not Applicable".